BioCentury | May 8, 2006
Finance

U.S. investment in Europe

...3i; Burrill & Co.; DVC Deutsche Venture Capital; AGF Private Equity; Quintiles Transnational Corp..; BayTech; Marubeni...
BioCentury | Jan 7, 2006
Financial News

CanBas raises $20 million

...SMBC Ventures and Mitsui . Nikko antfactory; MBL Venture Capital; Mizuho Capital; Nomura Securities; and Marubeni...
BioCentury | May 24, 2005
Financial News

elbion raises EUR 10 million

...Mitsubishi Corp. joined 3i; Burrill; DVC Deutsche Venture Capital; AGF; Quintiles PharmaBio Development; BayTech and Marubeni...
BioCentury | May 23, 2005
Finance

U.S. investment in Europe

...3i; Burrill & Co.; DVC Deutsche Venture Capital; AGF Private Equity; Quintiles Transnational Corp.; BayTech; Marubeni...
BioCentury | Jan 10, 2005
Finance

Ebb & Flow

...investors in elbion included AGF Private Equity; Quintiles PharmaBio Development; BayTech Venture Capital; and Japan's Marubeni...
BioCentury | Jan 10, 2005
Emerging Company Profile

Corporate Profile

...million) Investors: GlaxoSmithKline plc; 3i; Burrill & Co.; Deutsche Venture Capital; AGF; Baytech; PharmaBio Development; Marubeni...
BioCentury | Sep 16, 2002
Finance

Ebb & Flow

...million ($123 million). Merlin for the first time included Asian investors, with NIF Ventures and Marubeni...
BioCentury | Sep 9, 2002
Financial News

$91M first closing for a Merlin fund

...125 million ($123 million). Merlin said first time participants from Asia included NIF Ventures and Marubeni...
BioCentury | Nov 5, 2001
Company News

Acacia Research, Marubeni Corp. deal

...ACRI subsidiary CombiMatrix Corp. (Mulkilteo, Wash.) formed a joint venture with Marubeni. The Tokyo-based JV will...
...Japanese pharma and biotech companies and establish partnerships in Japanese genomics, proteomics and antibody markets. Marubeni...
...its acquisition of a minority interest in the JV. Acacia Research Corp. (ACRI), Pasadena, Calif. Marubeni...
BioCentury | Oct 29, 2001
Company News

CombiMatrix, Marubeni joint venture

...Research (ACRI) said its majority owned subsidiary, CombiMatrix (Pasadena, Calif.), formed a joint venture with Marubeni...
...and biotech companies and try to establish partnerships in Japanese genomics, proteomics and antibody markets. Marubeni...
Items per page:
1 - 10 of 11
BioCentury | May 8, 2006
Finance

U.S. investment in Europe

...3i; Burrill & Co.; DVC Deutsche Venture Capital; AGF Private Equity; Quintiles Transnational Corp..; BayTech; Marubeni...
BioCentury | Jan 7, 2006
Financial News

CanBas raises $20 million

...SMBC Ventures and Mitsui . Nikko antfactory; MBL Venture Capital; Mizuho Capital; Nomura Securities; and Marubeni...
BioCentury | May 24, 2005
Financial News

elbion raises EUR 10 million

...Mitsubishi Corp. joined 3i; Burrill; DVC Deutsche Venture Capital; AGF; Quintiles PharmaBio Development; BayTech and Marubeni...
BioCentury | May 23, 2005
Finance

U.S. investment in Europe

...3i; Burrill & Co.; DVC Deutsche Venture Capital; AGF Private Equity; Quintiles Transnational Corp.; BayTech; Marubeni...
BioCentury | Jan 10, 2005
Finance

Ebb & Flow

...investors in elbion included AGF Private Equity; Quintiles PharmaBio Development; BayTech Venture Capital; and Japan's Marubeni...
BioCentury | Jan 10, 2005
Emerging Company Profile

Corporate Profile

...million) Investors: GlaxoSmithKline plc; 3i; Burrill & Co.; Deutsche Venture Capital; AGF; Baytech; PharmaBio Development; Marubeni...
BioCentury | Sep 16, 2002
Finance

Ebb & Flow

...million ($123 million). Merlin for the first time included Asian investors, with NIF Ventures and Marubeni...
BioCentury | Sep 9, 2002
Financial News

$91M first closing for a Merlin fund

...125 million ($123 million). Merlin said first time participants from Asia included NIF Ventures and Marubeni...
BioCentury | Nov 5, 2001
Company News

Acacia Research, Marubeni Corp. deal

...ACRI subsidiary CombiMatrix Corp. (Mulkilteo, Wash.) formed a joint venture with Marubeni. The Tokyo-based JV will...
...Japanese pharma and biotech companies and establish partnerships in Japanese genomics, proteomics and antibody markets. Marubeni...
...its acquisition of a minority interest in the JV. Acacia Research Corp. (ACRI), Pasadena, Calif. Marubeni...
BioCentury | Oct 29, 2001
Company News

CombiMatrix, Marubeni joint venture

...Research (ACRI) said its majority owned subsidiary, CombiMatrix (Pasadena, Calif.), formed a joint venture with Marubeni...
...and biotech companies and try to establish partnerships in Japanese genomics, proteomics and antibody markets. Marubeni...
Items per page:
1 - 10 of 11